Metraipolis › archive › dc_0821ea90d699

Interplay Between MicroRNAs and Breast Cancer Therapies: Personalized Therapeutic Potential for HER2-Low Breast Cancer — Europe PMC PMID:41301038

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41301038
DOI
10.3390/cancers17223672
License (as archived)
solo-consultazione
Archived
2026-11-08T13:01:30.481Z
SHA-256 of the archived text
6c7f85221b7da32f951d3ef68b614ddfa21babc1c5d3a121f756e282e0fc54b1
Stable URL of this page
https://metraipolis.com/documento/dc_0821ea90d699

How to cite

Interplay Between MicroRNAs and Breast Cancer Therapies: Personalized Therapeutic Potential for HER2-Low Breast Cancer — Europe PMC PMID:41301038 — Europe PMC (en), https://europepmc.org/article/MED/41301038 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_0821ea90d699 (Metraipolis archive dc_0821ea90d699, sha256 6c7f85221b7da32f951d3ef68b614ddfa21babc1c5d3a121f756e282e0fc54b1)
BibTeX
@misc{dc0821ea90d699,
  title = {Interplay Between MicroRNAs and Breast Cancer Therapies: Personalized Therapeutic Potential for HER2-Low Breast Cancer — Europe PMC PMID:41301038},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41301038},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_0821ea90d699; sha256 6c7f85221b7da32f951d3ef68b614ddfa21babc1c5d3a121f756e282e0fc54b1},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41301038. Agents can read the archived copy with the MCP tool read_document.